These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 37692500)

  • 21. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
    Laranjeira AB; Yang SX
    Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-renewal of leukemia stem cells in Friend virus-induced erythroleukemia requires proviral insertional activation of Spi1 and hedgehog signaling but not mutation of p53.
    Hegde S; Hankey P; Paulson RF
    Stem Cells; 2012 Feb; 30(2):121-30. PubMed ID: 22083997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and Molecular State of Myeloid Leukemia Stem Cells.
    Xie X; Feng M; Wang Q; Wang J; Yin R; Li Y; Zhang H
    Adv Exp Med Biol; 2019; 1143():41-57. PubMed ID: 31338814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
    Lefort S; Maguer-Satta V
    Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.
    Zhang B; Nguyen LXT; Li L; Zhao D; Kumar B; Wu H; Lin A; Pellicano F; Hopcroft L; Su YL; Copland M; Holyoake TL; Kuo CJ; Bhatia R; Snyder DS; Ali H; Stein AS; Brewer C; Wang H; McDonald T; Swiderski P; Troadec E; Chen CC; Dorrance A; Pullarkat V; Yuan YC; Perrotti D; Carlesso N; Forman SJ; Kortylewski M; Kuo YH; Marcucci G
    Nat Med; 2018 May; 24(4):450-462. PubMed ID: 29505034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication.
    Hansen Q; Bachas C; Smit L; Cloos J
    Cancer Drug Resist; 2022; 5(2):344-367. PubMed ID: 35800375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTEN and leukemia stem cells.
    Fragoso R; Barata JT
    Adv Biol Regul; 2014 Sep; 56():22-9. PubMed ID: 24961634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer.
    Chavez-Gonzalez A; Bakhshinejad B; Pakravan K; Guzman ML; Babashah S
    Cell Oncol (Dordr); 2017 Feb; 40(1):1-20. PubMed ID: 27678246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
    Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
    Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukemia stem cells in drug resistance and metastasis.
    Deng CH; Zhang QP
    Chin Med J (Engl); 2010 Apr; 123(7):954-60. PubMed ID: 20497694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent progress on targeting leukemia stem cells.
    Ma XY; Wei L; Lei Z; Chen Y; Ding Z; Chen ZS
    Drug Discov Today; 2021 Aug; 26(8):1904-1913. PubMed ID: 34029689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of hematopoietic and leukemic stem cells by the immune system.
    Riether C; Schürch CM; Ochsenbein AF
    Cell Death Differ; 2015 Feb; 22(2):187-98. PubMed ID: 24992931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.
    Aramini B; Masciale V; Grisendi G; Bertolini F; Maur M; Guaitoli G; Chrystel I; Morandi U; Stella F; Dominici M; Haider KH
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukemia Stem Cells Microenvironment.
    Tabe Y; Konopleva M
    Adv Exp Med Biol; 2017; 1041():19-32. PubMed ID: 29204827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metoclopramide treatment blocks CD93-signaling-mediated self-renewal of chronic myeloid leukemia stem cells.
    Riether C; Radpour R; Kallen NM; Bürgin DT; Bachmann C; Schürch CM; Lüthi U; Arambasic M; Hoppe S; Albers CE; Baerlocher GM; Ochsenbein AF
    Cell Rep; 2021 Jan; 34(4):108663. PubMed ID: 33503440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities.
    Stahl M; Kim TK; Zeidan AM
    World J Stem Cells; 2016 Oct; 8(10):316-331. PubMed ID: 27822339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolutionarily conserved signaling pathways: acting in the shadows of acute myelogenous leukemia's genetic diversity.
    Heidel FH; Arreba-Tutusaus P; Armstrong SA; Fischer T
    Clin Cancer Res; 2015 Jan; 21(2):240-8. PubMed ID: 25593343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow microenvironment: The guardian of leukemia stem cells.
    Houshmand M; Blanco TM; Circosta P; Yazdi N; Kazemi A; Saglio G; Zarif MN
    World J Stem Cells; 2019 Aug; 11(8):476-490. PubMed ID: 31523368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting.
    Chen Y; Li J; Xu L; Găman MA; Zou Z
    Cell Death Discov; 2022 Sep; 8(1):397. PubMed ID: 36163119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.